We will positively impact people and our planet through responsible, sustainable practices that create a better, healthier world.
Stronger people
We are committed to serving our communities and creating a healthy, diverse, equitable and inclusive workplace where employees thrive
Healthier planet
We are committed to reducing our environmental impact on the world through responsible, sustainable operations
Good business
We are committed to helping customers improve patient outcomes and growing responsibly by pursuing quality and integrity in everything we do
Advance a culture of inclusion, engagement and belonging
Strengthen the diversity of our workforce and measure progress
20% reduction in carbon emissions for all Stryker facilities 2019-2024
commitments Responsibility Corporate Our
Corporate governance at Stryker
Board Governance and Nominating Committee
Carbon neutral for
Oversees Corporate Responsibility mattersall Stryker facilities by 2030*
*Scopes 1 and 2
CEO and senior leadership
Direct local management who are responsible for implementing the Board's risk management strategy
Corporate Responsibility Steering Committee
Oversees ESG strategy, goals and reporting; provides feedback to the CEO and leadership team and is comprised of business leaders from around the globe
Stryker Corporation published this content on 08 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2022 16:21:06 UTC.
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows:
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).